Point-by-point response from Roche to BMJ questions

Abstract
James Smith responds on behalf of Roche to some of the issues raised with regard to the Cochrane Review on oseltamivir published in the BMJ (doi:10.1136/bmj.b5106)

This publication has 0 references indexed in Scilit: